Press release
Lipid CMO Market Set to Surpass USD 2.1 Billion by 2034
Lipid CMO
Pune, India, November 2025 - Exactitude Consultancy reports that the Global Lipid Contract Manufacturing Organization (CMO) Market is poised to reach USD 2.1 billion by 2034, growing at a CAGR of 9.4% from 2025 to 2034. The market is gaining momentum due to the continued demand for lipid nanoparticles (LNPs) used in mRNA-based vaccines, gene therapies, and novel drug delivery systems.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72858
The global biopharmaceutical landscape is witnessing a structural shift toward outsourced lipid manufacturing, driven by scalability needs, quality assurance, and cost efficiency. Lipid CMOs are playing a critical role in ensuring reliable supply chains for both pandemic preparedness and next-generation therapeutics.
Key Takeaways
• Market Size: USD 850 million in 2024 → projected USD 2.1 billion by 2034
• CAGR: 9.4% (2025-2034)
• Key Growth Drivers: Expansion of mRNA vaccine technologies, demand for lipid nanoparticles (LNPs), and increased pharma outsourcing
• Major Players: Evonik Industries, CordenPharma, Croda International, Merck KGaA, Avanti Polar Lipids (CRODA), Nippon Fine Chemical, BioNTech Manufacturing Services, and Precision NanoSystems
• Regional Leaders: North America holds over 40% market share; Asia-Pacific emerging as fastest-growing hub
Market Story
The COVID-19 pandemic catalyzed a new era for lipid-based manufacturing. Lipids, once niche excipients, became critical components in mRNA vaccine formulations, particularly for Pfizer-BioNTech and Moderna. As vaccine and RNA therapeutics pipelines expand, the demand for custom lipids-ionizable, cationic, and PEGylated-has surged, prompting pharmaceutical companies to partner with specialized CMOs.
CordenPharma and Evonik Industries are expanding global lipid facilities in Switzerland, Germany, and the U.S. to address high-volume production, while Croda International has invested heavily in Avanti Polar Lipids to scale lipid nanoparticle development. These strategic investments are ensuring a steady supply chain and reducing manufacturing bottlenecks for upcoming mRNA-based flu, RSV, and oncology vaccines.
Market Segmentation
By Type:
• Ionizable Lipids
• PEGylated Lipids
• Phospholipids
• Neutral Lipids
• Cationic Lipids
By Application:
• mRNA Vaccines
• Gene Therapy
• siRNA & Oligonucleotide Delivery
• Liposomal Drug Formulations
By End User:
• Pharmaceutical Companies
• Biotechnology Firms
• Academic & Research Institutions
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/72858/lipid-cmo-market
Recent Developments
• September 2025: Evonik Industries launched a €70 million lipid production expansion at its Tippecanoe site (U.S.), increasing mRNA lipid output by 40%.
• July 2025: Croda International signed a multi-year agreement with Moderna to supply GMP-grade lipids for global vaccine production.
• May 2025: CordenPharma announced the opening of a new high-purity lipid synthesis facility in Liestal, Switzerland.
• April 2025: Merck KGaA invested €250 million in Darmstadt for advanced lipid nanoparticle (LNP) production capacity.
Expert Insight
"Lipids have transitioned from auxiliary excipients to core enablers of the genetic medicine revolution," said Dr. Hanna Ortiz, Senior Analyst at Exactitude Consultancy. "The growing complexity of RNA-based therapeutics is driving sustained demand for specialized CMOs capable of meeting global GMP standards."
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72858
Market Drivers
• Rising prevalence of chronic and genetic diseases driving RNA-based therapies
• Expanding biopharmaceutical R&D budgets and partnership-driven innovation
• Growing mRNA vaccine development for infectious diseases and cancer
• Government funding for local lipid production to reduce supply chain risk
Forecast and Regional Outlook
North America remains the largest market owing to the dominance of Moderna, Pfizer, and lipid manufacturers in the U.S. and Canada. Europe follows, supported by major CMO expansions in Germany, Switzerland, and the U.K. Meanwhile, Asia-Pacific (notably China, Japan, and South Korea) is expected to post the fastest CAGR, backed by government investments in biomanufacturing infrastructure and increasing local demand for LNP-based therapeutics.
Government Initiatives
• U.S. Department of Health and Human Services (HHS) announced continued funding under the Biomedical Advanced Research and Development Authority (BARDA) for lipid nanoparticle production scaling.
• European Commission initiated the EU FAB program to establish mRNA and lipid manufacturing reserves.
• Japan's PMDA introduced accelerated approval routes for lipid nanoparticle-based therapies in 2025.
Conclusion
The Lipid CMO Market stands at the intersection of biotechnology innovation and manufacturing excellence. As global demand for RNA and gene-based therapies grows, CMOs are strengthening their technical capabilities and regulatory compliance to ensure seamless delivery of high-quality lipids worldwide. The next decade promises deeper collaborations, facility expansions, and innovations that will redefine the future of precision medicine.
This report is also available in the following languages : Japanese (脂質CMO市場), Korean (지질 CMO 시장), Chinese (脂质CMO市场), French (Marché des CMO lipidiques), German (Lipid-CMO-Markt), and Italian (Mercato CMO dei lipidi), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72858/lipid-cmo-market#request-a-sample
Related Reports
Lipid Nanoparticles (LNP) Market
https://exactitudeconsultancy.com/reports/62110/global-lipid-nanoparticles-lnp-market
Lipid Contract Manufacturing Market
https://exactitudeconsultancy.com/reports/62144/global-lipid-contract-manufacturing-market
Liposomal and Lipid Nanoparticle Drug Delivery Systems Market
https://exactitudeconsultancy.com/reports/63156/global-liposomal-and-lipid-nanoparticle-drug-delivery-systems-market
mRNA Vaccine Core Enzyme Market
https://exactitudeconsultancy.com/reports/64421/global-mrna-vaccine-core-enzyme-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lipid CMO Market Set to Surpass USD 2.1 Billion by 2034 here
News-ID: 4257563 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Lipid
Key Trends Shaping the Future Lipid Market From 2025-2034: Advancements In Scala …
What industry-specific factors are fueling the growth of the lipid market?
The lipid market's expansion is projected to be fuelled by a growing demand for nutritional supplements. The increase in nutritional requirements resulting from a more active lifestyle or health condition is often met with supplementation. Lipid-based nutrient supplements - those where lipids supply the majority of the energy and also encompass protein, energy, essential fatty acids, and micronutrients - play…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Lipid Regulators Market Report 2024 - Lipid Regulators Market Trends And Growth
"The Business Research Company recently released a comprehensive report on the Global Lipid Regulators Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Lipid Research: Creative Biolabs Launches Its Lipid-Based Delivery Solutions
Creative Biolabs, a leading biotechnology company, unveiled its latest solutions for developing lipid-based delivery systems last week.
New York, USA - April 18, 2024 - "Liposomes as excellent drug delivery vehicles continuously drive innovation in drug delivery development and open up new breakthroughs and possibilities. Building on this momentum, we have designed a suite of solutions for lipid-based delivery system development," said an expert from the Lipid Research Department, Creative Biolabs.
Image:…
Creative Biolabs: Unlocking Lipid Biology With Complete Lipid Analysis Solutions
Creative Biolabs, a pioneer in the field of biotechnology, is delighted to announce the launch of cutting-edge assay and analysis solutions tailored specifically for liposome drug delivery.
New York, USA - March 26, 2024 - Liposomes, versatile lipid-based structures, have emerged as promising carriers for drug delivery due to their biocompatibility, flexibility, and capacity to encapsulate a wide range of therapeutics. To ensure the successful development of lipid-based drug delivery systems,…
Lipid Nanoparticles (LNP) Market Growth Is Attributed To The Increasing Demand F …
According to Precision Business Insights (PBI) latest report, the Lipid Nanoparticles (LNP) Market size is expected to be worth USD 675.0 Million in 2022, growing at a 7.5% CAGR from 2022 to 2028. The growing demand for therapeutic drugs and vaccinations to combat viral illnesses like Ebola, influenza, HIV, and other viruses, together with the traditional vaccine approach's failure to find vaccines in time for a crisis, are all contributing…
